|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
0.47/1.24
|
企業價值
21.86B
|
資產負債 |
每股賬面淨值
7.86
|
現金流量 |
現金流量率
0.05
|
損益表 |
收益
6.97B
|
每股收益
10.36
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/03 00:12 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipmentand instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas. |